Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.825 USD | -4.95% | -18.61% | -81.50% |
Financials (USD)
Sales 2024 * | 186M | Sales 2025 * | 247M | Capitalization | 523M |
---|---|---|---|---|---|
Net income 2024 * | -248M | Net income 2025 * | -201M | EV / Sales 2024 * | 5.13 x |
Net Debt 2024 * | 434M | Net Debt 2025 * | 469M | EV / Sales 2025 * | 4.02 x |
P/E ratio 2024 * |
-2.07
x | P/E ratio 2025 * |
-2.68
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.13% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | -4.95% | ||
1 week | -0.52% | ||
Current month | +16.36% | ||
1 month | +23.87% | ||
3 months | -63.71% | ||
6 months | -77.62% | ||
Current year | -80.43% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.81 | -5.73% | 4 460 008 |
24-05-20 | 1.92 | -4.95% | 8,110,157 |
24-05-17 | 2.02 | -7.76% | 8,137,826 |
24-05-16 | 2.19 | +2.10% | 12,992,736 |
24-05-15 | 2.145 | -3.81% | 15,793,797 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.43% | 523M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.65% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- PACB Stock